AltPep
Latest round
- Series B
Last raised
- Jun 2023
Total raised
- $76M
Investors
- 6
About AltPep
Based in the US, AltPep Corp.AltPep Corp. is focused on the diagnosis and treatment of amyloid diseases. The company was founded in 2019 and is headquartered in Seattle, US.AltPep Corporation specializes in innovative treatments and detection tools for amyloid diseases, including Alzheimer's and Parkinson's. The company's core offerings revolve around its AltPep platform, which utilizes a proprietary library of custom-designed synthetic peptides. These peptides are engineered to selectively bind to a-sheet toxic soluble oligomers, allowing for both early detection and neutralization of these harmful entities throughout the progression of amyloid diseases. The platform supports two primary product lines: SOBIN Therapeutics, aimed at targeting and neutralizing toxic oligomers in conjunction with early detection, and SOBA Diagnostics, which provides highly sensitive blood tests for the early identification of amyloid diseases.AltPep Corporation's revenue model is structured around partnerships with healthcare providers and research institutions, focusing on B2B transactions. The company's trademarked products, including SOBIN Therapeutics and SOBA Diagnostics, facilitate collaborations that may involve licensing agreements and joint development initiatives. These transactions are designed to streamline the adoption of their diagnostic and therapeutic solutions into clinical practice. Revenue is expected to be generated through the sale of the diagnostic tests and therapeutic products, with pricing plans tailored to specific client needs, ranging from one-time payments for diagnostic services to ongoing commitments for therapeutic applications.In June 2023, AltPep Corp. The company plans to further enhance its product lines by launching new diagnostic and therapeutic solutions, with specific release dates to be announced.
Who invested in AltPep
6 investors across 2 rounds
See all investors in AltPep
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about AltPep
Who invested in AltPep?
AltPep has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has AltPep raised?
AltPep has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did AltPep last raise money?
AltPep's most recent round on record is a Series B, in Jun 2023.
What does AltPep do?
AltPep is a biotechnology company.
Where is AltPep headquartered?
AltPep is headquartered in Seattle, US.
Which VCs invest in companies like AltPep?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at AltPep's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like AltPep? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.